| Literature DB >> 31117525 |
Xiachang Wang1, Muhammad Abbas2, Yinan Zhang1, Sherif I Elshahawi3, Larissa V Ponomareva, Zheng Cui, Steven G Van Lanen, Imran Sajid2, S Randal Voss, Khaled A Shaaban, Jon S Thorson.
Abstract
The structures and bioactivities of three unprecedented fused 5-hydroxyquinoxaline/alpha-keto acid amino acid metabolites (baraphenazines A-C, 1-3), two unique diastaphenazine-type metabolites (baraphenazines D and E, 4 and 5) and two new phenazinolin-type (baraphenazines F and G, 6 and 7) metabolites from the Himalayan isolate Streptomyces sp. PU-10A are reported. This study highlights the first reported bacterial strain capable of producing diastaphenazine-type, phenazinolin-type, and izumiphenazine A-type metabolites and presents a unique opportunity for the future biosynthetic interrogation of late-stage phenazine-based metabolite maturation.Entities:
Year: 2019 PMID: 31117525 PMCID: PMC6630045 DOI: 10.1021/acs.jnatprod.9b00289
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050